Common Stock, Value, Issued of Regencell Bioscience Holdings Ltd from 30 Jun 2020 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary: Regencell Bioscience Holdings Ltd quarterly Common Stock, Value, Issued in USD history and change rate from 30 Jun 2020 to 30 Jun 2025.
Regencell Bioscience Holdings Ltd Common Stock, Value, Issued for the quarter ending 30 Jun 2025 was $4,945, a 3704% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Value, Issued, Quarterly (USD)

Common Stock, Value, Issued, YoY Quarterly Change (%)

Regencell Bioscience Holdings Ltd Quarterly Common Stock, Value, Issued (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$4,945	+$4,815	+3704%	30 Jun 2025	20-F	31 Oct 2025	2025	FY
Q2 2024	$130	$0	0%	30 Jun 2024	20-F	31 Oct 2025	2025	FY
Q2 2023	$130	$0	0%	30 Jun 2023	20-F	25 Oct 2024	2024	FY
Q2 2022	$130	+$30	+30%	30 Jun 2022	20-F	27 Oct 2023	2023	FY
Q2 2021	$100	$0	0%	30 Jun 2021	20-F	31 Oct 2022	2022	FY
Q2 2020	$100			30 Jun 2020	20-F	29 Oct 2021	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.